ArticleTransplantation and cellular therapy2023

A Phase I Trial of SYK Inhibition with Fostamatinib in the Prevention and Treatment of Chronic Graft-Versus-Host Disease.

Chenyu Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.